Anti-CLL-1 antibodies and immunoconjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10266597
APP PUB NO 20180009894A1
SERIAL NO

15657472

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENENTECH INCCALIFORNIA USA CALIFORNIA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chiu, Cecilia San Carlos, US 10 132
Liang, Wei-Ching Foster City, US 71 1285
Polson, Andrew San Francisco, US 85 1705
Wu, Yan Foster City, US 454 4399
Zheng, Bing Mountain View, US 75 1171

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 23, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 23, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00